Vitolo Ottavio V. 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 23, 2019
Insider Transaction Report
Form 4
Vitolo Ottavio V.
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2019-12-19$43.47/sh+105,000$4,564,350→ 105,000 totalExercise: $43.47Exp: 2029-12-19→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.